Davis George Eric
Insider CIK 1380710 · BMRN SVP, General Counsel
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2026-09-02 | 2026-09-03 | 17,557 | $66.28 | $1.16M | 61,003 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2026-09-02 | 2026-09-03 | 17,557 | $66.28 | $1.16M | 61,003 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2026-03-18 | 2026-03-19 | 1,273 | $56.05 | $71.4K | 78,560 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2026-03-16 | 2026-03-17 | 34,690 | — | $0 | 34,690 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2026-03-16 | 2026-03-17 | 7,177 | $58.51 | $419.9K | 65,263 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2026-03-16 | 2026-03-17 | 14,570 | — | $0 | 79,833 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2026-02-26 | 2026-02-26 | 26,061 | $61.36 | $1.60M | 72,453 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2026-02-25 | 2026-02-26 | 6,177 | — | $0 | 89,467 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2026-02-25 | 2026-02-26 | 6,675 | — | $0 | 96,142 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2026-02-25 | 2026-02-26 | 2,372 | — | $0 | 98,514 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2025-03-17 | 2025-03-18 | 30,020 | — | $0 | 30,020 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2025-03-17 | 2025-03-18 | 12,940 | — | $0 | 82,915 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2025-03-14 | 2025-03-18 | 16,249 | $69.44 | $1.13M | 69,975 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2025-02-25 | 2025-02-27 | 9,367 | — | $0 | 86,224 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2025-02-25 | 2025-02-27 | 11,040 | — | $0 | 67,197 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2025-02-25 | 2025-02-27 | 9,660 | — | $0 | 76,857 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2024-05-28 | 2024-05-30 | 40,850 | — | $0 | 0 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2024-05-28 | 2024-05-30 | 38,071 | $74.46 | $2.83M | 58,936 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2024-05-28 | 2024-05-30 | 2,779 | $75.29 | $209.2K | 56,157 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2024-05-28 | 2024-05-30 | 40,850 | $63.10 | $2.58M | 97,007 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2024-05-02 | 2024-05-06 | 1,850 | — | $0 | 40,850 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2024-05-02 | 2024-05-06 | 1,850 | $63.10 | $116.7K | 58,007 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2024-05-02 | 2024-05-06 | 1,850 | $85.01 | $157.3K | 56,157 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2024-04-30 | 2024-05-06 | 301 | $68.65 | $20.7K | 56,157 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2024-03-28 | 2024-04-01 | 24,602 | $88.34 | $2.17M | 55,856 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2024-03-15 | 2024-03-19 | 22,990 | — | $0 | 22,990 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2024-03-15 | 2024-03-19 | 21,699 | $83.87 | $1.82M | 80,458 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2024-03-15 | 2024-03-19 | 10,260 | — | $0 | 102,157 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2024-02-27 | 2024-02-29 | 6,284 | — | $0 | 91,897 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2024-02-27 | 2024-02-29 | 9,063 | — | $0 | 85,613 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2024-02-27 | 2024-02-29 | 20,840 | — | $0 | 76,550 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2023-12-13 | 2023-12-14 | 13,764 | $95.30 | $1.31M | 55,710 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2023-08-08 | 2023-08-09 | 11,000 | $89.42 | $983.6K | 69,474 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | G Gift | 2023-05-16 | 2023-05-18 | 210 | — | $0 | 80,474 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2023-04-28 | 2023-05-18 | 317 | $66.88 | $21.2K | 80,684 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2023-03-16 | 2023-03-17 | 19,957 | $93.41 | $1.86M | 80,367 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2023-03-15 | 2023-03-17 | 20,320 | — | $0 | 20,320 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2023-03-15 | 2023-03-17 | 8,900 | — | $0 | 103,349 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2023-03-15 | 2023-03-17 | 3,025 | $87.74 | $265.4K | 100,324 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2023-02-28 | 2023-03-02 | 20,200 | — | $0 | 76,925 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2023-02-28 | 2023-03-02 | 10,100 | — | $0 | 87,025 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2023-02-28 | 2023-03-02 | 7,424 | — | $0 | 94,449 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2023-02-24 | 2023-02-28 | 1,474 | — | $0 | 0 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2023-02-24 | 2023-02-28 | 1,474 | $67.81 | $100.0K | 56,725 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2022-08-09 | 2022-08-11 | 47,526 | — | $0 | 0 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2022-08-09 | 2022-08-11 | 3,690 | $96.34 | $355.5K | 55,251 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2022-08-09 | 2022-08-11 | 47,526 | $67.81 | $3.22M | 102,777 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2022-08-09 | 2022-08-11 | 47,526 | $95.93 | $4.56M | 55,251 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2022-07-08 | 2022-07-11 | 7,398 | $90.00 | $665.8K | 58,941 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2022-05-02 | 2022-05-04 | 15,347 | — | $0 | 0 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2022-05-02 | 2022-05-04 | 15,347 | $37.46 | $574.9K | 81,686 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2022-05-02 | 2022-05-04 | 15,347 | $80.38 | $1.23M | 66,339 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2022-04-29 | 2022-05-04 | 341 | $62.41 | $21.3K | 66,339 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2022-04-25 | 2022-04-27 | 2,669 | — | $0 | 0 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2022-04-25 | 2022-04-27 | 2,669 | $37.46 | $100.0K | 65,998 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2022-03-21 | 2022-03-23 | 6,129 | $81.29 | $498.2K | 63,329 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2022-03-16 | 2022-03-17 | 1,252 | $80.72 | $101.1K | 69,458 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2022-03-15 | 2022-03-17 | 26,520 | — | $0 | 26,520 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2022-03-15 | 2022-03-17 | 8,290 | $78.27 | $648.9K | 70,710 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2022-03-15 | 2022-03-17 | 11,040 | — | $0 | 79,000 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2022-03-08 | 2022-03-10 | 9,370 | — | $0 | 67,960 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2021-08-02 | 2021-08-04 | 5,518 | $76.69 | $423.2K | 58,590 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2021-05-03 | 2021-05-04 | 2,584 | $78.30 | $202.3K | 66,197 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2021-05-03 | 2021-05-04 | 2,089 | $78.30 | $163.6K | 64,108 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2021-04-30 | 2021-05-04 | 341 | $62.41 | $21.3K | 68,781 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2021-04-19 | 2021-04-20 | 2,709 | — | $0 | 0 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2021-04-19 | 2021-04-20 | 2,709 | $26.49 | $71.8K | 71,149 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2021-04-19 | 2021-04-20 | 2,709 | $79.58 | $215.6K | 68,440 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2021-03-22 | 2021-03-23 | 1,391 | $78.52 | $109.2K | 68,440 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2021-03-16 | 2021-03-17 | 1,252 | $77.21 | $96.7K | 69,831 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2021-03-15 | 2021-03-17 | 25,650 | — | $0 | 25,650 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2021-03-15 | 2021-03-17 | 5,014 | $78.39 | $393.0K | 71,083 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2021-03-15 | 2021-03-17 | 10,420 | — | $0 | 76,097 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2020-05-01 | 2020-05-04 | 12,504 | $89.38 | $1.12M | 65,677 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2020-04-30 | 2020-05-04 | 339 | $62.59 | $21.2K | 78,181 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2020-03-20 | 2020-03-24 | 3,309 | $73.05 | $241.7K | 77,842 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2020-03-16 | 2020-03-17 | 28,790 | — | $0 | 28,790 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2020-03-16 | 2020-03-17 | 10,100 | — | $0 | 81,151 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2020-03-13 | 2020-03-17 | 7,244 | $84.50 | $612.1K | 71,051 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2020-03-03 | 2020-03-04 | 9,586 | — | $0 | 78,295 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2019-11-26 | 2019-11-27 | 3,190 | $79.66 | $254.1K | 68,709 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | G Gift | 2019-06-05 | 2019-06-07 | 300 | — | $0 | 71,899 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2019-04-30 | 2019-06-07 | 309 | $68.78 | $21.3K | 72,199 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2019-03-25 | 2019-03-26 | 3,363 | $87.86 | $295.5K | 71,890 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2019-03-22 | 2019-03-26 | 3,309 | $88.05 | $291.4K | 75,253 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2019-03-19 | 2019-03-21 | 7,907 | $93.92 | $742.6K | 78,562 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2019-03-15 | 2019-03-19 | 23,450 | — | $0 | 23,450 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2019-03-15 | 2019-03-19 | 9,370 | — | $0 | 86,469 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2019-03-15 | 2019-03-19 | 6,648 | $94.53 | $628.4K | 77,099 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2019-03-01 | 2019-03-05 | 840 | $94.76 | $79.6K | 83,747 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2019-03-01 | 2019-03-05 | 11,853 | — | $0 | 84,587 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2018-09-14 | 2018-09-18 | 1,400 | $99.45 | $139.2K | 73,550 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2018-09-14 | 2018-09-18 | 616 | $99.46 | $61.3K | 72,734 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2018-09-14 | 2018-09-18 | 200 | $99.46 | $19.9K | 73,350 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2018-09-13 | 2018-09-17 | 12,000 | $99.57 | $1.19M | 74,950 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2018-06-04 | 2018-06-06 | 1,414 | $92.07 | $130.2K | 86,950 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2018-04-30 | 2018-06-06 | 309 | $68.78 | $21.3K | 88,364 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2018-03-23 | 2018-03-27 | 3,350 | $81.35 | $272.5K | 87,989 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2018-03-22 | 2018-04-27 | 3,308 | $81.36 | $269.1K | 91,326 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2018-03-22 | 2018-03-26 | 3,295 | $81.36 | $268.1K | 91,339 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2018-03-16 | 2018-03-20 | 3,818 | $83.88 | $320.3K | 94,634 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2018-03-15 | 2018-03-19 | 38,760 | — | $0 | 38,760 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2018-03-15 | 2018-03-19 | 3,757 | $83.57 | $314.0K | 86,332 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2018-03-15 | 2018-03-19 | 12,120 | — | $0 | 98,452 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2018-03-05 | 2018-03-07 | 2,105 | $79.04 | $166.4K | 90,089 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2018-03-02 | 2018-03-06 | 2,071 | $79.86 | $165.4K | 92,194 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2018-02-26 | 2018-04-26 | 11,601 | — | $0 | 94,343 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2018-02-26 | 2018-02-28 | 11,523 | — | $0 | 94,265 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2018-02-01 | 2018-02-05 | 30,000 | — | $0 | 0 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2018-02-01 | 2018-02-05 | 30,000 | $90.66 | $2.72M | 82,942 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2018-02-01 | 2018-02-05 | 30,000 | $38.59 | $1.16M | 112,942 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2017-11-30 | 2017-12-04 | 1,200 | $85.64 | $102.8K | 82,942 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2017-06-23 | 2017-06-27 | 9,844 | — | $0 | 30,000 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2017-06-23 | 2017-06-27 | 9,844 | $38.59 | $379.9K | 93,425 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2017-06-23 | 2017-06-27 | 9,844 | $96.60 | $950.9K | 83,581 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2017-06-09 | 2017-06-13 | 3,775 | — | $0 | 0 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2017-06-09 | 2017-06-13 | 5,464 | — | $0 | 0 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2017-06-09 | 2017-06-13 | 5,464 | $21.51 | $117.5K | 79,806 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2017-06-09 | 2017-06-13 | 3,775 | $26.49 | $100.0K | 83,581 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2017-06-05 | 2017-06-07 | 9,471 | $91.04 | $862.2K | 74,342 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2017-06-02 | 2017-06-06 | 1,488 | $90.72 | $135.0K | 83,813 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2017-05-16 | 2017-05-17 | 1,146 | — | $0 | 0 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2017-05-16 | 2017-05-17 | 1,146 | $14.39 | $16.5K | 85,301 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2017-05-15 | 2017-05-17 | 1,096 | $91.50 | $100.3K | 84,155 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2017-05-05 | 2017-05-09 | 2,500 | — | $0 | 39,844 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2017-05-05 | 2017-05-09 | 2,500 | $38.59 | $96.5K | 87,751 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2017-05-05 | 2017-05-09 | 2,500 | $100.34 | $250.8K | 85,251 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2017-04-28 | 2017-05-09 | 302 | $70.30 | $21.2K | 85,251 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2017-03-22 | 2017-03-24 | 36,280 | — | $0 | 36,820 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2017-03-22 | 2017-03-24 | 11,220 | — | $0 | 84,949 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2017-03-16 | 2017-03-17 | 2,238 | $91.96 | $205.8K | 73,729 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2017-03-15 | 2017-03-17 | 2,995 | $92.50 | $277.0K | 75,967 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2017-03-06 | 2017-03-08 | 1,498 | $93.32 | $139.8K | 78,962 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2017-03-03 | 2017-03-07 | 1,596 | $93.95 | $149.9K | 80,460 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2017-02-24 | 2017-02-28 | 11,258 | — | $0 | 82,056 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2016-11-18 | 2016-11-22 | 5,000 | $38.59 | $193.0K | 42,344 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2016-11-18 | 2016-11-22 | 5,000 | $90.42 | $452.1K | 70,798 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2016-11-18 | 2016-11-22 | 5,000 | $38.59 | $193.0K | 75,798 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | G Gift | 2016-10-07 | 2016-11-22 | 360 | — | $0 | 70,798 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2016-08-01 | 2016-08-03 | 2,167 | $100.00 | $216.7K | 71,158 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2016-07-14 | 2016-07-18 | 2,656 | $38.59 | $102.5K | 4,823 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2016-07-14 | 2016-07-18 | 2,656 | $38.59 | $102.5K | 73,325 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2016-07-07 | 2016-07-11 | 2,167 | $90.00 | $195.0K | 70,669 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | G Gift | 2016-06-16 | 2016-07-11 | 120 | — | $0 | 72,836 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2016-06-03 | 2016-06-07 | 1,488 | $90.00 | $133.9K | 72,956 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2016-05-13 | 2016-05-17 | 1,096 | $82.71 | $90.7K | 74,444 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2016-05-10 | 2016-05-10 | 4,658 | $86.32 | $402.1K | 75,540 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2016-05-09 | 2016-05-10 | 10,000 | $84.55 | $845.5K | 80,198 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2016-05-06 | 2016-05-10 | 1,696 | $80.80 | $137.0K | 90,198 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2016-04-29 | 2016-05-10 | 414 | $51.26 | $21.2K | 91,894 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2016-03-15 | 2016-03-17 | 34,270 | — | $0 | 34,270 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2016-03-15 | 2016-03-17 | 15,290 | — | $0 | 91,480 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2016-03-14 | 2016-03-16 | 1,996 | $86.21 | $172.1K | 76,190 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2016-03-03 | 2016-03-07 | 2,180 | $89.57 | $195.3K | 78,186 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2016-02-29 | 2016-03-02 | 17,656 | $81.87 | $1.45M | 80,366 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2016-02-24 | 2016-02-26 | 5,328 | — | $0 | 98,022 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2016-02-24 | 2016-02-26 | 6,860 | — | $0 | 72,854 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2016-02-24 | 2016-02-26 | 19,840 | — | $0 | 92,694 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | J Other | 2015-12-16 | 2017-10-13 | 0 | — | $0 | 66,960 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2015-12-16 | 2015-12-17 | 1,362 | $100.00 | $136.2K | 66,156 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | G Gift | 2015-06-08 | 2015-06-08 | 120 | — | $0 | 67,618 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2015-06-04 | 2015-06-08 | 1,488 | $120.46 | $179.2K | 67,738 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2015-05-18 | 2015-05-19 | 2,558 | $125.26 | $320.4K | 69,226 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2015-05-15 | 2015-05-19 | 1,096 | $122.78 | $134.6K | 71,784 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2015-05-08 | 2015-05-12 | 1,696 | $121.66 | $206.3K | 72,880 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2015-04-30 | 2015-05-12 | 730 | $51.26 | $37.4K | 74,576 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2015-03-13 | 2015-03-17 | 14,484 | — | $0 | 15,347 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2015-03-13 | 2015-03-17 | 516 | — | $0 | 2,709 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2015-03-13 | 2015-03-17 | 516 | $26.49 | $13.7K | 74,362 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2015-03-13 | 2015-03-17 | 14,484 | $37.46 | $542.6K | 88,846 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2015-03-13 | 2015-03-17 | 15,000 | $120.87 | $1.81M | 73,846 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2015-03-03 | 2015-03-05 | 21,900 | — | $0 | 21,900 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2015-03-03 | 2015-03-05 | 9,600 | — | $0 | 73,846 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2015-03-02 | 2015-03-04 | 20,000 | $26.49 | $529.8K | 3,225 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2015-03-02 | 2015-03-04 | 23,000 | $108.31 | $2.49M | 64,246 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2015-03-02 | 2015-03-04 | 23,000 | $26.49 | $609.3K | 87,246 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2014-11-25 | 2014-11-28 | 20,000 | $26.49 | $529.8K | 26,225 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2014-11-25 | 2014-11-28 | 20,000 | $89.75 | $1.79M | 64,426 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2014-11-25 | 2014-11-28 | 20,000 | $26.49 | $529.8K | 84,426 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2014-10-30 | 2014-11-03 | 15,000 | $26.49 | $397.4K | 46,225 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2014-10-30 | 2014-11-03 | 15,000 | $26.49 | $397.4K | 79,426 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2014-10-30 | 2014-11-03 | 15,000 | $83.20 | $1.25M | 64,426 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2014-09-19 | 2014-09-23 | 17,536 | $21.51 | $377.2K | 0 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2014-09-19 | 2014-09-23 | 17,536 | $69.75 | $1.22M | 64,426 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2014-09-19 | 2014-09-23 | 17,536 | $21.51 | $377.2K | 81,962 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2014-06-04 | 2014-06-05 | 42,700 | — | $0 | 42,700 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2014-06-04 | 2014-06-05 | 11,400 | — | $0 | 64,426 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | D To issuer | 2014-06-03 | 2014-06-05 | 3,562 | $60.00 | $213.7K | 53,026 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | G Gift | 2014-05-30 | 2014-06-05 | 180 | $23.21 | $4.2K | 56,588 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2014-05-12 | 2014-05-14 | 1,096 | $59.30 | $65.0K | 57,864 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2014-05-12 | 2014-05-19 | 1,096 | $57.44 | $63.0K | 56,768 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2014-05-08 | 2014-05-12 | 1,696 | $56.78 | $96.3K | 58,960 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2014-04-30 | 2014-05-12 | 704 | $29.69 | $20.9K | 61,360 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2014-02-20 | 2014-02-24 | 20,000 | $21.51 | $430.2K | 17,536 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2014-02-20 | 2014-02-24 | 20,000 | $21.51 | $430.2K | 80,656 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2014-02-20 | 2014-02-24 | 20,000 | $80.00 | $1.60M | 60,656 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2014-02-14 | 2014-02-19 | 10,500 | — | $0 | 60,656 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2013-05-15 | 2013-05-17 | 49,000 | — | $0 | 49,000 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2013-05-15 | 2013-05-17 | 8,400 | — | $0 | 50,108 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2013-05-14 | 2013-05-15 | 20,000 | $21.51 | $430.2K | 37,536 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2013-05-14 | 2013-05-15 | 20,000 | $70.34 | $1.41M | 41,708 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2013-05-14 | 2013-05-15 | 20,000 | $21.51 | $430.2K | 61,708 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2013-05-13 | 2013-05-14 | 2,590 | $69.29 | $179.5K | 41,708 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2013-05-12 | 2013-05-14 | 1,096 | $67.68 | $74.2K | 44,298 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2013-05-08 | 2013-05-10 | 1,664 | $65.32 | $108.7K | 45,394 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2013-05-03 | 2013-05-07 | 3,562 | — | $0 | 0 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2013-05-03 | 2013-05-07 | 2,292 | — | $0 | 1,147 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2013-05-03 | 2013-05-07 | 3,562 | $17.54 | $62.5K | 50,620 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2013-05-03 | 2013-05-07 | 5,854 | $67.19 | $393.3K | 47,058 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2013-05-03 | 2013-05-07 | 2,292 | $14.39 | $33.0K | 52,912 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2013-04-30 | 2013-05-07 | 858 | $23.21 | $19.9K | 47,058 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2013-03-04 | 2013-03-06 | 4,000 | $17.86 | $71.4K | 0 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2013-03-04 | 2013-03-06 | 4,000 | $60.18 | $240.7K | 46,200 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2013-03-04 | 2013-03-06 | 4,000 | $17.86 | $71.4K | 50,200 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2013-02-27 | 2013-02-28 | 3,417 | — | $0 | 226,083 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2013-02-27 | 2013-02-28 | 4,583 | $14.39 | $65.9K | 221,500 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2013-02-27 | 2013-02-28 | 4,583 | $14.39 | $65.9K | 54,200 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2013-02-27 | 2013-02-28 | 3,417 | $17.54 | $59.9K | 49,617 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2013-02-27 | 2013-02-28 | 8,000 | $56.90 | $455.2K | 46,200 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2012-11-19 | 2012-11-19 | 7,363 | — | $0 | 229,500 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2012-11-19 | 2012-11-19 | 7,363 | $48.50 | $357.1K | 51,322 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2012-11-19 | 2012-11-19 | 7,363 | $17.54 | $129.1K | 58,685 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2012-11-12 | 2012-11-14 | 10,137 | — | $0 | 236,863 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2012-11-12 | 2012-11-14 | 10,137 | $48.63 | $493.0K | 51,322 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2012-11-12 | 2012-11-14 | 1,438 | $48.70 | $70.0K | 61,459 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2012-11-12 | 2012-11-14 | 10,137 | $17.54 | $177.8K | 62,897 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2012-11-12 | 2012-11-14 | 1,329 | $38.00 | $50.5K | 52,651 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2012-11-09 | 2012-11-14 | 35,521 | — | $0 | 247,000 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2012-11-09 | 2012-11-14 | 6,979 | — | $0 | 282,521 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2012-11-09 | 2012-11-14 | 45,000 | — | $0 | 289,500 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2012-11-09 | 2012-11-14 | 35,521 | $17.54 | $623.0K | 138,822 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2012-11-09 | 2012-11-14 | 6,979 | $14.39 | $100.4K | 103,301 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2012-11-09 | 2012-11-14 | 45,000 | $17.33 | $779.8K | 96,322 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2012-11-09 | 2012-11-14 | 17,500 | $48.55 | $849.6K | 51,322 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2012-11-09 | 2012-11-14 | 50,000 | $48.55 | $2.43M | 68,822 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2012-11-09 | 2012-11-14 | 20,000 | $48.00 | $960.0K | 118,822 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2012-10-31 | 2012-11-14 | 109 | $21.76 | $2.4K | 52,760 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2012-05-11 | 2012-05-15 | 40,000 | $14.39 | $575.6K | 334,500 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2012-05-11 | 2012-05-15 | 2,309 | $37.07 | $85.6K | 51,322 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2012-05-11 | 2012-05-15 | 40,000 | $14.39 | $575.6K | 91,322 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2012-05-11 | 2012-05-15 | 35,000 | $37.94 | $1.33M | 56,322 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2012-05-11 | 2012-05-15 | 5,000 | $38.08 | $190.4K | 51,322 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2012-05-08 | 2012-05-10 | 32,500 | — | $0 | 374,500 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2012-05-08 | 2012-05-10 | 32,500 | — | $0 | 374,500 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2012-05-08 | 2012-05-10 | 32,500 | — | $0 | 374,500 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2012-05-08 | 2012-05-10 | 13,000 | — | $0 | 53,631 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2012-05-08 | 2012-05-10 | 13,000 | — | $0 | 53,631 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2012-05-08 | 2012-05-10 | 13,000 | — | $0 | 53,631 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2012-04-30 | 2012-05-10 | 980 | $19.35 | $19.0K | 40,631 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2012-04-30 | 2012-05-10 | 980 | $19.35 | $19.0K | 40,631 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2012-04-30 | 2012-05-10 | 980 | $19.35 | $19.0K | 40,631 | SEC↗ |